Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) Peptide
Aperçu rapide pour Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) Peptide (ABIN939674)
Antigène
Origine
Source
Application
-
-
Type de proteíne
- Synthetic
-
Séquence
- KDHYENLYCV VSGEKHFLFH PPSDRPFIPY ELYTPATYQL TEEGTFKVVD
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PLA2 G2 antibody,
Alternative Names: PLA2G4B control peptide, PLA2G4B antibody Blocking Peptide, Anti-PLA2G4B Blocking Peptide, phospholipase A2, group IVB, cytosolic Blocking Peptide, FLJ42498 Blocking Peptide, HsT16992 Blocking Peptide, cPLA2-beta Blocking Peptide, PLA2G4B, PLAG4B-2, PLAG4B 2, PLAG4B-2 Blocking Peptide, PLAG4B 2 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
-
Sujet
- This gene transcribes naturally-occurring mRNAs that are co-transcribed products of the neighboring JMJD7 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined. Alternative splicing of this gene results in different transcript variants, some of which are candidates for nonsense-mediated decay (NMD).
-
Poids moléculaire
- 114 kDa
Antigène
-